company-page-background
Bristol-Myers Squibb Logo
Bristol-Myers Squibb
 3.8
(43 Reviews)

Bristol-Myers Squibb News

Bristol-Myers Squibb logo
Bristol-Myers Squibb
Yahoo FinanceOctober 8, 2022

Shares of Bristol Myers Squibb Co. slid 0.77% to $69.70 Friday, on what proved to be an all-around poor trading session for the stock market, with the S&P...

Bristol Myers Squibb Co. stock outperforms market despite losses on the day
Yahoo Finance
Bristol Myers Squibb Co. stock outperforms market despite losses on the day
https://www.marketwatch.com/story/bristol-myers-squibb-co-stock-outperforms-market-despite-losses-on-the-day-01665175275-6fbd0bad72b9
Bristol-Myers Squibb logo
Bristol-Myers Squibb
Yahoo FinanceOctober 8, 2022

In this article, we will take a look at some of the notable pharma stocks to buy according to Steven Boyd’s Armistice Capital. To skip our analysis of Steven Boyd’s profile, investment strategy, and 13F holdings, you can go directly to see the 5 Best Pharmaceutical Stocks to Buy According to Steven…

10 Best Pharmaceutical Stocks to Buy According to Steven Boyd’s Armistice Capital
Yahoo Finance
10 Best Pharmaceutical Stocks to Buy According to Steven Boyd’s Armistice Capital
https://finance.yahoo.com/news/10-best-pharmaceutical-stocks-buy-175755572.html
Bristol-Myers Squibb logo
Bristol-Myers Squibb
PharmiWeb.comOctober 3, 2022

All three of these stocks are attractively valued even though they’re beating the market this year.

Bear Market Bargains: 3 Dividend Stocks to Buy Now
PharmiWeb.com
Bear Market Bargains: 3 Dividend Stocks to Buy Now
https://www.fool.com/investing/2022/10/03/bear-market-bargains-3-dividend-stocks-to-buy-now/
Bristol-Myers Squibb logo
Bristol-Myers Squibb
PharmiWeb.comOctober 3, 2022

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Resignation of Eli Casdin as a Class I... | October 3, 2022

CENTURY THERAPEUTICS, INC. : Change in Directors or Principal Officers (form 8-K)
PharmiWeb.com
CENTURY THERAPEUTICS, INC. : Change in Directors or Principal Officers (form 8-K)
https://www.marketscreener.com/quote/stock/CENTURY-THERAPEUTICS-INC-123820661/news/CENTURY-THERAPEUTICS-INC-Change-in-Directors-or-Principal-Officers-form-8-K-41913745/
Bristol-Myers Squibb logo
Bristol-Myers Squibb
PharmiWeb.comOctober 3, 2022

According to Future Market Analysis, a leading market research and competitive intelligence provider, the antibodies market will grow at a 21x pace in upcoming decades, surpassing US$ 601.614 Billion by the end of 2031.As per FMI studies, the leading players in the antibodies market include F. Ho...

Antibodies Market to surpass USD 601.614 Billion by 2031, Says FMI
PharmiWeb.com
Antibodies Market to surpass USD 601.614 Billion by 2031, Says FMI
https://www.pharmiweb.com/press-release/2022-10-03/antibodies-market-to-surpass-usd-601614-billion-by-2031-says-fmi
Bristol-Myers Squibb logo
Bristol-Myers Squibb
Seeking AlphaOctober 2, 2022

The company’s medicines received over 10 regulatory approvals in Europe, Japan, and the US in the first half of 2022. Read more to see our price target on BMY.

Bristol-Myers Squibb: A Gem Amid Macroeconomic Uncertainties
Seeking Alpha
Bristol-Myers Squibb: A Gem Amid Macroeconomic Uncertainties
https://seekingalpha.com/article/4544208-bristol-myers-squibb-a-gem-in-a-period-of-macroeconomic-uncertainties
Bristol-Myers Squibb logo
Bristol-Myers Squibb
ascopubs.orgOctober 1, 2022

Shares of Bristol Myers Squibb Co. sank 0.86% to $71.09 Friday, on what proved to be an all-around dismal trading session for the stock market, with the S&P...

Bristol Myers Squibb Co. stock outperforms market despite losses on the day
ascopubs.org
Bristol Myers Squibb Co. stock outperforms market despite losses on the day
https://www.marketwatch.com/story/bristol-myers-squibb-co-stock-outperforms-market-despite-losses-on-the-day-01664570468-4c720fca2e3d
Bristol-Myers Squibb logo
Bristol-Myers Squibb
San Diego Union-TribuneSeptember 25, 2022

Kyle Peterson, AIA, managing principal of HMC Architects’ San Diego office, has been promoted to the company’s new civic practice leader.

Peterson new civic practice leader at HMC Architects
San Diego Union-Tribune
Peterson new civic practice leader at HMC Architects
https://www.sandiegouniontribune.com/movers-shakers/story/2022-09-25/peterson-new-civic-practice-leader-at-hmc-architects
Bristol-Myers Squibb logo
Bristol-Myers Squibb
MedgadgetSeptember 22, 2022

Business and community leaders gathered yesterday at Capital Health, one of the area’s largest employers and a provider of health care in the Trenton communit

Capital Health Launches Trenton Neighborhood Initiative Leveraging $10 Million of Investment in Local Community
Medgadget
Capital Health Launches Trenton Neighborhood Initiative Leveraging $10 Million of Investment in Local Community
https://www.trentondaily.com/capital-health-launches-trenton-neighborhood-initiative-leveraging-10-million-of-investment-in-local-community/
Bristol-Myers Squibb logo
Bristol-Myers Squibb
MedgadgetSeptember 22, 2022

As damage assessments and utility restorations continue in Puerto Rico, the island could now face the possibility of interruptions for many pharmaceutical and medtech exports to the U.S., according to an industry-leading analyst forecasting operations for energy, agriculture and supply chain logisti…

Prescription drug disruptions may arise in Puerto Rico amid Fiona’s damage
Medgadget
Prescription drug disruptions may arise in Puerto Rico amid Fiona’s damage
https://www.foxweather.com/extreme-weather/puerto-rico-prescription-drugs-medtech-exports-fiona
Bristol-Myers Squibb logo
Bristol-Myers Squibb
MedgadgetSeptember 22, 2022

The Biden Administration told the U.S. Supreme Court on Wednesday that it should turn down a request by Amgen Inc to review a decision that invalidated patents on its blockbuster cholesterol drug Repatha.

Biden Administration asks Supreme Court to reject Amgen's Repatha patent appeal
Medgadget
Biden Administration asks Supreme Court to reject Amgen's Repatha patent appeal
https://www.reuters.com/legal/litigation/biden-administration-asks-supreme-court-reject-amgens-repatha-patent-appeal-2022-09-21/
Bristol-Myers Squibb logo
Bristol-Myers Squibb
MedgadgetSeptember 22, 2022

After championing the controversial Monsanto acquisition, Bayer CEO Werner Baumann’s contract is set to expire in 2024.

Bayer's CEO Talks About the Pharma Company's Future
Medgadget
Bayer's CEO Talks About the Pharma Company's Future
https://www.businessinsider.com/bayers-ceo-talks-about-the-pharma-companys-future-2022-9
Bristol-Myers Squibb logo
Bristol-Myers Squibb
MedgadgetSeptember 22, 2022

ParkourSC will speak alongside pharmaceutical supply chain experts at Merck, Bristol Myers Squibb and AeroSafe Global ParkourSC, a leader in supply chain technology solutions, today announced its participation and

ParkourSC to Present in Panelist Discussion at LogiPharma U.S.A. 2022
Medgadget
ParkourSC to Present in Panelist Discussion at LogiPharma U.S.A. 2022
https://www.benzinga.com/pressreleases/22/09/b28963964/parkoursc-to-present-in-panelist-discussion-at-logipharma-u-s-a-2022
Bristol-Myers Squibb logo
Bristol-Myers Squibb
Digital JournalSeptember 21, 2022

Shares of Bristol Myers Squibb Co. slumped 0.66% to $69.73 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the...

Bristol Myers Squibb Co. stock outperforms competitors despite losses on the day
Digital Journal
Bristol Myers Squibb Co. stock outperforms competitors despite losses on the day
https://www.marketwatch.com/story/bristol-myers-squibb-co-stock-outperforms-competitors-despite-losses-on-the-day-01663706490-2491fe94ad5a